FDA Harnesses Search Engine Power To Warn Of Risks Of Buying Accutane Online
This article was originally published in The Pink Sheet Daily
Executive Summary
Web page is designed to warn consumers of risks of isotretinoin when they search online for Accutane or a generic version.
You may also be interested in...
Accutane iPLEDGE Debut On Track Despite Calls For Delay
FDA confirmed that it would not delay the March 1 implementation of the isotretinoin risk management program.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.
Darzalex Surpasses Stelara As J&J’s Best-Selling Drug
Sales of Stelara are expected to begin tapering off later this year when the first biosimilars launch in mid-2024 in Europe and later in the US.